
USFDA APPLICATION NUMBER - 22287 / DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - 30MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DEXLANSOPRAZOLE(UNII: UYE4T5I70X) (DEXLANSOPRAZOLE - UNII:UYE4T5I70X) | DEXLANSOPRAZOLE | 60mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions |
|---|---|
| aluminum oxide(LMI26O6933) | |
| carrageenan(5C69YCD2YJ) | |
| FD&C Blue No. 2(L06K8R7DQK) | |
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |
| HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6) | |
| low-substituted hydroxypropyl cellulose, unspecified(2165RE0K14) | |
| magnesium carbonate(0E53J927NA) | |
| Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A(NX76LV5T8J) | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)(74G4R6TH13) | |
| Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)(5KY68S2577) | |
| polyethylene glycol 8000(Q662QK8M3B) | |
| polysorbate 80(6OZP39ZG8H) | |
| potassium chloride(660YQ98I10) | |
| silicon dioxide(ETJ7Z6XBU4) | |
| STARCH, CORN(O8232NY3SJ) | |
| sucrose(C151H8M554) | |
| talc(7SEV7J4R1U) | |
| titanium dioxide(15FIX9V2JP) | |
| triethyl citrate(8Z96QXD6UM) |